We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GWGH
3701
DELISTED
GWG Holdings, Inc
GWGH
$33K ﹤0.01%
3,789
-114
-3% -$889
SUNS
3702
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
$33K ﹤0.01%
2,603
+2,419
+1,315% +$31.5K
BRID icon
3703
Bridgford Foods
BRID
$58.3M
$32K ﹤0.01%
1,768
+1,457
+468% +$25.2K
KNTK icon
3704
Kinetik
KNTK
$4.3B
$32K ﹤0.01%
5,748
+5,548
+2,774% +$35.5K
PPH icon
3705
VanEck Pharmaceutical ETF
PPH
$985M
$32K ﹤0.01%
507
-12,783
-96% -$808K
ROKU icon
3706
Roku
ROKU
$23.4B
$32K ﹤0.01%
170
-5,968
-97% -$944K
ZLAB icon
3707
Zai Lab
ZLAB
$2.91B
$32K ﹤0.01%
388
+225
+138% +$18.1K
ABTC
3708
American Bitcoin Corp
ABTC
$529M
– –
0
– –
EGRX
3709
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$32K ﹤0.01%
765
-1,301
-63% -$56.9K
OSH
3710
DELISTED
Oak Street Health, Inc.
OSH
$32K ﹤0.01%
+599
New +$26.8K
EIDX
3711
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$32K ﹤0.01%
628
-1,042
-62% -$46.8K
BBDC icon
3712
Barings BDC
BBDC
$975M
$31K ﹤0.01%
3,895
-2,434
-38% -$19.4K
CARM
3713
DELISTED
Carisma Therapeutics
CARM
$31K ﹤0.01%
1,090
-790
-42% -$15.8K
ELA icon
3714
Envela
ELA
$416M
$31K ﹤0.01%
7,044
+6,668
+1,773% +$28.1K
KYMR icon
3715
Kymera Therapeutics
KYMR
$9.76B
$31K ﹤0.01%
+970
New +$29.6K
NIO icon
3716
NIO
NIO
$11.3B
$31K ﹤0.01%
1,455
+81
+6% +$1.25K
TARA icon
3717
Protara Therapeutics
TARA
$235M
$31K ﹤0.01%
1,828
+1,736
+1,887% +$40.3K
VALU icon
3718
Value Line
VALU
$353M
$31K ﹤0.01%
1,266
+915
+261% +$23.5K
VCEL icon
3719
Vericel Corp
VCEL
$2.26B
$31K ﹤0.01%
1,686
-12,764
-88% -$211K
WSBC icon
3720
WesBanco
WSBC
$4.09B
$31K ﹤0.01%
1,441
-5,328
-79% -$113K
OSB
3721
DELISTED
Norbord Inc.
OSB
$31K ﹤0.01%
1,062
-4,667
-81% -$146K
BP icon
3722
BP
BP
$110B
$30K ﹤0.01%
1,691
-31,336
-95% -$678K
CRH icon
3723
CRH
CRH
$64.6B
$30K ﹤0.01%
827
+606
+274% +$22.8K
KDP icon
3724
Keurig Dr Pepper
KDP
$42.8B
$30K ﹤0.01%
1,103
+1,098
+21,960% +$32.2K
SU icon
3725
Suncor Energy
SU
$77B
$30K ﹤0.01%
2,472
-782
-24% -$12.2K
147 148
149
150 151

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.